54 Biggest Movers From Yesterday

Gainers

• Coda Octopus Group, Inc. CODA shares jumped 45.8% to close at $14.16 on Thursday after the company reported better-than-expected Q2 EPS and sales results.
• Mmtec, Inc. MTC gained 37.5% to close at $7.70.
• Cemtrex, Inc. CETX gained 33.9% to close at $3.00.
• Red Robin Gourmet Burgers, Inc. RRGB gained 31.5% to close at $33.48 following news Vintage Capital has suggested the company's Board conduct a review of strategic alternatives. The firm said it would be prepared to offer $40 per share for Red Robin following confirmatory due dilligence.
• ContraVir Pharmaceuticals, Inc. CTRV rose 27.2% to close at $10.11.
• Ruhnn Holding Limited RUHN shares gained 23% to close at $4.01.
• DryShips Inc. DRYS gained 22.8% to close at $3.88 after SPII offered $4 per share for a merger with the company.
• CEL-SCI Corporation CVM rose 19.8% to close at $5.99.
• Aeterna Zentaris Inc. AEZS climbed 19.1% to close at $2.75.
• Everspin Technologies, Inc. MRAM gained 18.5% to close at $7.68.
• Ocular Therapeutix, Inc. OCUL surged 18.3% to close at $4.52.
• Aspen Aerogels, Inc. ASPN climbed 16.8% to close at $6.25.
• CrowdStrike Holdings, Inc. CRWD rose 16.5% to close at $67.56 after climbing 70.59% on Wednesday.
• Axovant Gene Therapies Ltd. AXGT surged 16% to close at $4.85.
• RH RH rose 15.8% to close at $109.91 after the company reported better-than-expected earnings for its first quarter and raised FY2019 guidance.
• Neuronetics, Inc. STIM surged 15.2% to close at $11.99.
• Callaway Golf Company ELY gained 14.4% to close at $18.19 following new 9.22% stake from JANA Partners.
• Hi-Crush Inc. HCR climbed 14.2% to close at $2.73.
• Cortexyme, Inc. CRTX gained 14.2% to close at $31.42.
• Summit Materials, Inc. SUM rose 14.1% to close at $15.62.
• Nordic American Tankers Limited NAT shares gained 12.3% to close at $2.29.
• Fennec Pharmaceuticals Inc. FENC gained 12.1% to close at $3.70.
• Taitron Components Incorporated TAIT jumped 12% to close at $3.65.
• Mayville Engineering Company, Inc. MEC shares gained 11.5% to close at $14.90.
• Vitamin Shoppe, Inc. VSI gained 11.5% to close at $4.18.
• Marinus Pharmaceuticals, Inc. MRNS rose 11.1% to close at $4.22.
• Senmiao Technology Limited AIHS shares climbed 10.8% to close at $4.82.
• Century Aluminum Company CENX gained 10.7% to close at $6.30.
• Frontline Ltd. FRO rose 10.7% to close at $7.99 following reports that a tanker had been struck by a torpedo off the coast of UAE.
• Revolve Group, Inc. RVLV rose 10.7% to close at $40.40.
• Netshoes (Cayman) Limited NETS rose 10.5% to close at $3.80 after Brazilian company Magazine Luiza SA lifted its offer to buy Netshoes to $3.7 per share.
• Verrica Pharmaceuticals Inc. VRCA surged 10.5% to close at $9.87.
• Millicom International Cellular S.A. TIGO shares rose 10.4% to close at $55.00 after Kinnevik withdrew public offering of shares in Millicom due to unfavorable market condition.
• ENGlobal Corporation ENG surged 9.7% to close at $0.9874 after the company reported it won a spot as 1 of 3 prime contractors on a US Military $124 million automated fuel handling contract.
• CPFL Energia S.A. CPL gained 8.4% to close at $15.59.
• Oxford Industries Inc OXM rose 8.4% to close at $74.58 after the company reported better-than-expected earnings for its first quarter on Wednesday.
• DRDGOLD Limited DRD shares rose 7.5% to close at $2.4400.
• PaySign, Inc. PAYS gained 5.5% to close at $12.55.

Losers

• Savara Inc. SVRA shares tumbled 75.2% to close at $2.62 on Thursday. Savara said a Phase 3 study dubbed IMPALA that evaluated its Molgradex for the treatment of autoimmune alveolar pulmonary proteinosis, or aPAP, did not meet its primary endpoint. An average A-aDO2 improvement of 12.1 mmHg was observed in the continuous dosing compared to an 8.8 mmHg improvement in the placebo arm, with an estimated 4.6 mmHg treatment difference suggesting the primary endpoint was not met.
• Arcadia Biosciences, Inc. RKDA declined 31.8% to close at $4.03 after the company announced a direct offering of 1.49 million shares at $5.035 per share.
• Hemispherx Biopharma, Inc. HEB dipped 20.9% to close at $5.35 after the company announced the first patient has been treated in the Phase 2 recurrent ovarian cancer program evaluating Ampligen in combination with Pembrolizumab and Cisplatin.
• SharpSpring, Inc. SHSP dropped 16.3% to close at $12.70. SharpSpring priced its 2.05 million share common stock offering at $13 per share.
• TuanChe Limited TC dipped 14.6% to close at $2.69.
• Immuron Limited IMRN dropped 14.5% to close at $3.00 after climbing 14.52% on Wednesday.
• Seres Therapeutics Inc MCRB fell 13.7% to close at $2.8300 after reporting a $60 million common stock offering.
• Neptune Wellness Solutions Inc. NEPT fell 13.1% to close at $4.25 after reporting fourth-quarter sales of $5.79 million, up from $5.394 million year-over-year.
• Avadel Pharmaceuticals plc AVDL shares dipped 12.8% to close at $2.65.
• Jaguar Health, Inc. JAGX dropped 11.3% to close at $6.907 after declining 23.27% on Wednesday.
• HEXO Corp. HEXO fell 9.2% to close at $5.86 after reporting Q3 results.
• Mohawk Group Holdings, Inc. MWK shares declined 8.3% to close at $9.17.
• Mersana Therapeutics, Inc. MRSN shares fell 7.8% to close at $3.90.
• Cooper-Standard Holdings Inc. CPS dropped 6.6% to close at $39.12. Goldman Sachs downgraded Cooper-Standard from Neutral to Sell and lowered the price target from $51 to $36.
• Provention Bio, Inc. PRVB fell 5.4% to close at $11.21 after the company cancelled its secondary offering.
• iCAD, Inc. ICAD fell 3.1% to close at $6.02. iCAD priced its 1.636 million shares at $5.50 per share.